MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway
D.-W. Wang, Y.-Q. Wang, H.-S. Shu Department of Neurosurgery, the Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People’s Republic of China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway, by D.-W. Wang, Y.-Q. Wang, H.-S. Shu, published in Eur Rev Med Pharmacol Sci 2018; 22 (5): 1241-1248–DOI: 10.26355/eurrev_201803_14464–PMID: 29565480” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadMiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
D.-W. Wang, Y.-Q. Wang, H.-S. Shu
MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 18
Pages: 9236-9236
DOI: 10.26355/eurrev_202009_22992